Liao WM, Xu LM. Conventional treatment combined with Rehabilitation New Fluid and flupentixol and melitracen tablets for treatment of reflux esophagitis in elderly patients.
Shijie Huaren Xiaohua Zazhi 2019;
27:598-604. [DOI:
10.11569/wcjd.v27.i9.598]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND
Conventional treatment for reflux esophagitis (RE) is not very effective, because psychosocial factors have a certain impact on the disease progression and treatment outcome in RE patients. Exploring new treatments for RE on the basis of mental and psychological factors has become a hot spot in clinical research.
AIM
To investigate the efficacy and safety of conventional therapy combined with Rehabilitation New Fluid and flupentixol and melitracen tablets in the treatment of elderly patients with RE.
METHODS
A total of 120 elderly patients with RE who were treated at our hospital from October 2017 to October 2018 were enrolled. They were randomly divided into three groups (A, B, and C), with 40 cases in each group. Group A patients were treated with conventional therapy, group B patients were treated with conventional therapy combined with Rehabilitation New Fluid, and group C patients were treated with conventional therapy combined with Rehabilitation New Fluid and flupentixol and melitracen tablets. The clinical efficacy, reflux diagnostic questionnaire (RDQ) score, Hamilton anxiety scale (HAMA) score, Hamilton depression scale (HAMD) score, SF-36 score, and adverse reactions were compared among the three groups.
RESULTS
The total effective rates of groups B and C were significantly higher than that of group A (P < 0.05). After treatment, the RDQ score, HAMA score, and HAMD score of group C were significantly lower than those of groups A and B (P < 0.05). After treatment, the physical function, physical role, physical pain, and mental health scores of patients in group C were significantly higher than those of groups A and B (P < 0.05). There was no significant difference in the incidence of adverse reactions among the three groups (P > 0.05).
CONCLUSION
Conventional treatment combined with Rehabilitation New Fluid and flupentixol and melitracen tablets has good clinical efficacy in the treatment of RE in elderly patients, which can effectively improve the clinical symptoms, depression and anxiety, and the quality of life of patients.
Collapse